Monday, June 15, 2026

Samsung SDI Secures 1.5 Billion KRW ESS Battery Supply Deal: What This Means

Samsung SDI secures a $1 billion contract for ESS batteries in the U.S., enhancing its market position amid rising demand for renewables.

Landing Giants: How Aircraft Tires Handle Extreme Conditions

Known as a jumbo jet, Boeing's B747...

Samsung’s AI Innovations: How the Bespoke Combo Washers are Redefining Laundry in 2026

Samsung Electronics showcases AI appliances at Best Buy, emphasizing innovation and premium branding in the U.S. market.

Tag: trial

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Can Donanemab Expand Alzheimer’s Treatment to Lewy Body Dementia? Key Insights from Korean Lilly’s Latest Clinical Trials

Lilly has launched a global trial for Kisunla, targeting Lewy body dementia, aiming to expand its Alzheimer's treatment to this underserved area.

DA-2811 vs. Farxiga: Which Diabetes Treatment Proves More Effective in 2026?

Dong-A ST's DA-2811 shows comparable efficacy to Farxiga in diabetes treatment, with positive clinical trial results presented at ADA.

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST's Meta via will present DA-1726, a dual-action obesity treatment, at the EASL Congress 2026, showcasing promising clinical trial results.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

A New Study Suggests Selenium Could Help With One of Chemotherapy’s Most Disruptive Side Effects

A study reveals high-dose selenium can reduce exercise-related dysfunction in ovarian cancer patients undergoing chemotherapy.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Revolutionary TNZ Alloy Implants: 4x Stronger Than Titanium for Better Dental Health

Korean researchers have developed a next-gen implant alloy that outperforms titanium, mimicking bone properties and ensuring higher strength.

Unlock Healthier Hair: JW Shinyak’s Ducray Neoptide Expert Shows 93.6% User Satisfaction in Global Study

JW Shinyak's Ducray Neoptide Expert shows significant hair improvement in a global trial, with high user satisfaction across ages and conditions.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.